Literature DB >> 17489033

Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies.

Vincenzo Stanghellini1, David Armstrong, Hubert Mönnikes, Peter Berghöfer, Gudrun Gatz, Karna Dev Bardhan.   

Abstract

BACKGROUND/AIMS: The growing importance of symptom assessment is evident from the numerous clinical studies on gastroesophageal reflux disease (GERD) assessing treatment-induced symptom relief. However, to date, the a priori selection of criteria defining symptom relief has been arbitrary. The present study was designed to prospectively identify GERD symptom thresholds for the broad spectrum of GERD-related symptoms assessed by the validated reflux questionnaire (ReQuest) and its subscales, ReQuest-GI (gastrointestinal symptoms) and ReQuest-WSO (general well-being, sleep disturbances, other complaints), in individuals without evidence of GERD.
METHODS: In this 4-day evaluation in Germany, 385 individuals without evidence of GERD were included. On the first day, participants completed the ReQuest, the Gastrointestinal Symptom Rating Scale, and the Psychological General Well-Being scale. On the other days, participants filled in the ReQuest only. GERD symptom thresholds were calculated for ReQuest and its subscales, based on the respective 90th percentiles.
RESULTS: GERD symptom thresholds were 3.37 for ReQuest, 0.95 for ReQuest-GI, and 2.46 for ReQuest-WSO.
CONCLUSION: Even individuals without evidence of GERD may experience some mild symptoms that are commonly ascribed to GERD. GERD symptom thresholds derived in this study can be used to define the global symptom relief in patients with GERD. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17489033     DOI: 10.1159/000101083

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  2 in total

Review 1.  The Quality of Care for Gastroesophageal Reflux Disease.

Authors:  Rena Yadlapati; Lara Dakhoul; John E Pandolfino; Rajesh N Keswani
Journal:  Dig Dis Sci       Date:  2016-12-27       Impact factor: 3.199

Review 2.  Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?

Authors:  Anita Gasiorowska; Choo Hean Poh; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-12-10       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.